Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters

PharmaCompass has recently put out an analysis of the sales potential for the drugs approved by the FDA in the record-breaking 2018.  It’s important to recognize that such forecasts are imperfect and that, once marketed, the prospects for each drug can change – for better or worse. Nevertheless, such predictions are a useful guide to early sales expectations.